Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 17 of 17

List	Outcome	Time frame	Description
Primary	Primary Outcomes:
Primary	Part A
Primary	i. Time to progression
Primary	ii. Incidence, CTC grade and type of Aes, clinically significant laboratory abnormalities or changes in vital signs, and ECG changes
Primary	Part B
Secondary	Secondary Outcomes:
Secondary	Part A
Secondary	i. Objective response
Secondary	ii. Disease control at 8 weeks
Secondary	iii. Time to death
Secondary	iv. WHO performance status
Secondary	v. QOL and LCS from the FACT-L questionnaire
Secondary	Part B
Secondary	i. Objective response in subjects following treatment with the alternate study treatment
Secondary	ii. Disease control at 8 weeks in subjects following treatment with the alternate study treatment
Secondary	iii. WHO performance status in subjects following treatment with the alternate study treatment
Secondary	iv. QOL and LCS from the FACT-L questionnaire in subjects following treatment with the alternate study treatment

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00059722/registered